{
  "trial_id": "NCT00205660",
  "trial_group": "obesity",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, body mass index (BMI), duration of schizophrenia, duration of current antipsychotic treatment, baseline total body fat, baseline insulin sensitivity, baseline fasting plasma triglyceride, baseline high sensitivity C-reactive protein (hsCRP), smoking status, alcohol use, physical activity level, dietary habits, baseline glucose levels, baseline lipid levels, baseline medication use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "BMI",
          "body mass index (BMI)"
        ],
        [
          "DEXA Total Fat",
          "baseline total body fat"
        ],
        [
          "Whole Body Sensitivity",
          "baseline insulin sensitivity"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Weight",
        "Waist Circumference"
      ],
      "remaining_candidate_features": [
        "duration of schizophrenia",
        "duration of current antipsychotic treatment",
        "baseline fasting plasma triglyceride",
        "baseline high sensitivity C-reactive protein (hsCRP)",
        "smoking status",
        "alcohol use",
        "physical activity level",
        "dietary habits",
        "baseline glucose levels",
        "baseline lipid levels",
        "baseline medication use"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Schizophrenia, Baseline Antipsychotic Medication, Body Mass Index, Fasting Plasma Glucose, Fasting Plasma Insulin, Fasting Plasma Triglycerides, High Sensitivity C-Reactive Protein (hsCRP),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "BMI",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "Weight",
        "Waist Circumference",
        "DEXA Total Fat",
        "Whole Body Sensitivity"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Duration of Schizophrenia",
        "Baseline Antipsychotic Medication",
        "Fasting Plasma Glucose",
        "Fasting Plasma Insulin",
        "Fasting Plasma Triglycerides",
        "High Sensitivity C-Reactive Protein (hsCRP)"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Waist Circumference, HbA1c, Fasting Plasma Glucose, Fasting Plasma Insulin, Triglycerides, HDL Cholesterol, LDL Cholesterol, Systolic Blood Pressure, Diastolic Blood Pressure, Duration of Schizophrenia, Duration of Antipsychotic Treatment, Type of Antipsychotic Treatment.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "BMI",
          "Body Mass Index"
        ],
        [
          "Waist Circumference",
          "Waist Circumference"
        ]
      ],
      "remaining_reference_features": [
        "Weight",
        "DEXA Total Fat",
        "Whole Body Sensitivity"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "HbA1c",
        "Fasting Plasma Glucose",
        "Fasting Plasma Insulin",
        "Triglycerides",
        "HDL Cholesterol",
        "LDL Cholesterol",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Duration of Schizophrenia",
        "Duration of Antipsychotic Treatment",
        "Type of Antipsychotic Treatment."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of schizophrenia, duration of antipsychotic treatment, type of antipsychotic pretreatment, smoking status, history of diabetes, family history of diabetes, fasting plasma glucose, fasting plasma insulin, high sensitivity C-reactive protein (hsCRP), fasting plasma triglyceride, systolic blood pressure, diastolic blood pressure.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "BMI",
          "body mass index (BMI)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Weight",
        "Waist Circumference",
        "DEXA Total Fat",
        "Whole Body Sensitivity"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "duration of schizophrenia",
        "duration of antipsychotic treatment",
        "type of antipsychotic pretreatment",
        "smoking status",
        "history of diabetes",
        "family history of diabetes",
        "fasting plasma glucose",
        "fasting plasma insulin",
        "high sensitivity C-reactive protein (hsCRP)",
        "fasting plasma triglyceride",
        "systolic blood pressure",
        "diastolic blood pressure"
      ]
    }
  }
}